Cancer Genomics
- Cancer PHGKB -
From National Institutes of Health Web Sites
- A Surprising Match: Cancer Immunotherapy and Mismatch Repair
Francis Collins, Director's Blog, June 9, 2015 - Approaches to Blue Ribbon Panel Recommendations: The Case of Lynch Syndrome
- Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01)
NCI Funding Announcement September 1, 2017 - Approval of Osimertinib and Necitumumab Increases Lung Cancer Treatment Options
- Aspirin to Reduce Cancer Risk
- Biomarker Signatures of Prostate Cancer
NIH Research Matters, July 12, 2016 - Biomarker Test Could Reduce Unnecessary Biopsies to Detect Prostate Cancer
NCI, June 9, 2017 - BRCA population screening for predicting breast cancer: for or against?
G Lippi et al, Ann Trans Med, July 2017 - Bringing Precision to Screening for Cancer
- Cancer Control P.L.A.N.E.T. portal
Cancer Control P.L.A.N.E.T. portal provides access to data and resources that can help planners, program staff, and researchers design, implement and evaluate evidence-based cancer control programs. - Cancer Moonshot Blue Ribbon Panel Report
- Cancer Moonshot℠
- CCG Funding Opportunities
Biospecimen Processing and Storage - Check out genetic conditions and tests associated with pancreatic cancer
from the NIH Genetic Testing Registry - Checking In on Cancer Checkpoint Inhibitors
- Childhood Cancer Genomics (PDQ®) Health Professional Version
- Crizotinib Shows Promise for Childhood Cancers
- Decoding Telomere Biology and Cancer Risk
NIH Intramural Research, 2017 - Detecting early signs of cancer in the blood
NIH Research matters, August 29, 2017 - Divide and Conquer: The Molecular Diagnosis of Cancer
- DNA Misfolding Revealed as Novel Oncogenic Mechanism
- Dual-Biomarker Blood Test Shows Promise for Pancreatic Cancer Early Detection
NCI News, August 9, 2017 - Enhanced Risk-Based Lung Cancer Screening May Prevent More Deaths than Current Approaches
- Establishing UniversalLynch Syndrome Screening in the Community
- FDA Approves Alectinib for ALK-Positive Non-Small Cell Lung Cancer
- FDA Approves Pembrolizumab for Tumors with Specific Genetic Features
NCI, June 20, 2017 - Find our which genetic conditions and tests are associated with thyroid cancer
from the NIH Genetic Testing Registry - Find out about genetic conditions and tests associated with kidney cancer
from the NIH Genetic Testing Registry - For Some Children with Cancer, Genomic Information May Help Guide Treatment Decisions
- Gene Fusion May Drive Rare Childhood Brain Tumor
- Genetic disorders and tests associated with gastric cancer
From the NIH Genetic Testing Registry - Genetics of Breast and Gynecologic Cancers (PDQ®)
NCI, October 2016 - Genetics of Colorectal Cancer (PDQ®) Health Professional Version PDQ Cancer Genetics Editorial Board.
NCI, February 2016 - Genetics of Prostate Cancer (PDQ®) -Health Professional Version
PDQ Cancer Genetics Editorial Board, NCI, May 2017 - Genetics of Skin Cancer (PDQ®)–Health Professional Version
- Genomic Study Seeks Clues to Help Explain Breast Cancer Disparities
NCI, June 13, 2017 - Head and Neck Cancer: Building the Evidence Base for Precision Oncology
Posted on February 10, 2015 by Dr. Francis Collins - Hereditary Breast and Ovarian Cancers: Moving Toward More Precise Prevention
NIH Director Blog Post, April 14, 2015 - How Genomics Is Shaping Precision Medicine in Oncology
- Insights from the Precision Public Health Summit
- Kidney (Renal Cell) Cancer—Patient Version
- Large Study Verifies Cancer Risk for Women Carrying BRCA1 or BRCA2 Mutations
NCI, July 112, 2017 - Longitudinal Study Charts Brain Tumor Evolution
A Blum, NCI, TCGA< July 8, 2016 - Metabolomics in Population-Based Research
- Most cases of lung cancer are due to smoking; however, there are other risk factors including family history.
- NCI study identifies essential genes for cancer immunotherapy
NCI, August 7, 2017 - NCI-COG Pediatric MATCH trial to test targeted drugs in childhood cancers
NCI, July 2017 - NCI-DOE Collaboration Paving Way for Large-Scale Computational Cancer Science
- NCI-MATCH trial will link targeted cancer drugs to gene abnormalities
- NCI-MATCH: A Status Report and Future Directions
- Neratinib Approved by FDA for HER2-Positive Breast Cancer
NCI, August 23, 2017 - NIH launches largest-ever study of breast cancer genetics in black women
Findings could inform breast cancer disparities, NIH, July 6, 2016 - Noninvasive strategies for lung cancer testing
NIH Research Matters, March 7, 2017 - Office of Cancer Survivorship
- Pre-Application Webinar on Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes
NCI, October 4, 2017- REGISTER NOW - Precision Medicine and Population Health
Cross Cutting Research Area in the NCI Division of Cancer Control and Population Sciences - Precision Medicine: Who Benefits from Aspirin to Prevent Colorectal Cancer?
Francis Collins, NIH Director, March 24, 2015 - Prevention and Early Detection for Hereditary Cancer Syndromes
Division of Cancer Control and Population Sciences, NCI, 2017 - Prevention and Early Detection for Hereditary Cancer Syndromes
NCI website with resources, events and funding - Prostate Cancer Prevention
- Random Mutations Play Major Role in Cancer
NIH Director Blog, April 4,2017 - Researchers report initial feasibility of identifying patients who are exceptional responders to cancer therapy
- Stomach (Gastric) Cancer Prevention (PDQ®)–Health Professional Version
- Study Uses Open Data to Analyze “Normal” Tissue Near Tumors
- Targeted Photoimmunotherapy Approach for Cancer Moves Forward
- The Cancer Genome Atlas
- The Cancer Genome Atlas (TCGA) Data Portal
Portal provides a platform for researchers to search, download, and analyze data sets generated by TCGA - The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
Tomczak K, et al. Contemp Oncol (Pozn). 2015; 19(1A): A68-A77. - The National Cancer Moonshot Begins to Take Shape
F Collins, NIH, February 2016 - The NCI Cancer Epidemiology Descriptive Cohort Database
Provides descriptive information on cohorts studying cancer as a primary outcome. - Thyroid Cancer—Patient Version
- Tumor DNA Sequencing in Cancer Treatment
- Two-Drug Combination Approved for Lung Cancers with BRAF Mutations
NCI, July 18, 2017 - Using Gene Expression to Diagnose Lung Cancer More Accurately
- What is hereditary diffuse gastric cancer?
from the NIH Genetics Home Reference - With FDA Approval, Gefitinib Returns to U.S. Market for Some Patients with Lung Cancer
.png)
No hay comentarios:
Publicar un comentario